medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-17-156-162medsovet-2713Research ArticleГАСТРОЭНТЕРОЛОГИЯGASTROENTEROLOGYПищевая аллергия у детей: с чем связан ее рост?Food allergies in children: why has there been an increase in the prevalence rates?ЗахароваИ. Н.ZakharovaI. N.

Захарова Ирина Николаевна – доктор медицинских наук, профессор, заслуженный врач России, заведующая кафедрой педиатрии с курсом поликлинической педиатрии им. академика Г.Н. Сперанского ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, член исполкома Союза педиатров России, полный член EAACI, ESPGHAN

Москва

БережнаяИ. В.BerezhnayaI. V.

Бережная Ирина Владимировна – кандидат медицинских наук, доцент кафедры педиатрии с курсом поликлинической педиатрии им. академика Г.Н. Сперанского

Москва

ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of RussiaRussian Federation201821102018017156162Copyright © Захарова И.Н., Бережная И.В., 20182018Захарова И.Н., Бережная И.В.Zakharova I.N., Berezhnaya I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2713

Во всех странах мира отмечен рост аллергической патологии. В последние годы ученые говорят о том, что до 30–40% взрослого населения страдают различными формами аллергии (гастроинтестинальной, кожной, респираторной в изолированном или комбинированном вариантах). Несмотря на более глубокое понимание патогенеза атопических заболеваний и достижения фармакологии, тенденции к снижению числа детей с этой патологией не отмечается. Экспертами разных специальностей (педиатрами, аллергологами, дерматологами, иммунологами, гастроэнтерологами) активно обсуждается роль микробиоты кишечника среди механизмов развития пищевой аллергии. В статье рассматриваются вопросы патогенеза пищевой аллергии и атопического дерматита у детей, обсуждаются возможности применения пробиотиков в комплексной терапии с учетом результатов клинических мировых исследований.

The prevalence of allergic diseases and asthma are increasing worldwide. Scientists say up to 30–40% of the adult population have various forms of allergy (gastrointestinal, skin, respiratory, isolated or combined) in recent years. There is no tendency for the number of children with this pathology to reduce despite a deeper understanding of the pathogenesis of atopic diseases and the achievements of pharmacology. Experts in various health areas (paediatricians, allergists, dermatologists, immunologists, gastroenterologists) actively discuss the role of the intestinal microbiota in the mechanisms of the development of food allergies. The article discusses the pathogenesis of food allergies and atopic dermatitis in children, discusses the possibility of using probiotics in complex therapy, taking into account the results of global clinical studies.

детипищевая аллергияатопический дерматитгастроинтестинальные проявлениямикробиота кишечникапробиотикипатогенез развития пищевой аллергииchildrenfood allergiesatopic dermatitisgastrointestinal manifestationsintestinal microbiotaprobioticspathogenesis of food allergiesReferencesSur G, Sur ML, Sur D, Coroian A, Floca E. Immunological Reactions in Atopic Dermatitis and Possible Improvement of Probiotics. Pharm Anal Acta, 2015, 6: 9. doi: 10.4172/21532435.1000420.Sur G, Sur ML, Sur D, Coroian A, Floca E. Immunological Reactions in Atopic Dermatitis and Possible Improvement of Probiotics. Pharm Anal Acta, 2015, 6: 9. doi: 10.4172/21532435.1000420.Прошутинская Д.В., Чикин В.В., Знаменская Л.Ф. и др. Федеральные клинические рекомендации по ведению больных атопическим дерматитом. 2015. [Электронный ресурс]. Режим доступа: http: //www.cnikvi.ru/docs/clinic_recs/bolezni-kozhi-i-pridatkovkozhi/atopicheskiy_dermatitProshutinskaya DV, Chikin VV, Znamenskaya LF. Federal clinical guidelines for the management of patients with atopic dermatitis. 2015. [Electronic resource]. Access mode: http: //www.cnikvi.ru/docs/clinic_recs/bolezni-kozhi-i-pridatkovkozhi/atopicheskiy_dermatitCipriani F, Dondi A, Ricci G. Recent advances in epidemiology and prevention of atopic eczema. Pediatr Allergy Immunol, 2014, 25(7): 630–638.Cipriani F, Dondi A, Ricci G. Recent advances in epidemiology and prevention of atopic eczema. Pediatr Allergy Immunol, 2014, 25(7): 630–638.Hwang CY, Chen YJ, Lin MW et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta DermVenereol, 2010, 90(6): 589-594.Hwang CY, Chen YJ, Lin MW et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta DermVenereol, 2010, 90(6): 589-594.Shaw ТЕ, Currie GP, Koudelka CW et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol, 2011, 131(1): 67-73.Shaw ТЕ, Currie GP, Koudelka CW et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol, 2011, 131(1): 67-73.Ильина Н.И., Федоскова Т.Г. Роль аллергических заболеваний в общеклинической практике. РМЖ, 2004, 14: 876-879.Ilyina NI, Fedoskova TG. The role of allergic diseases in clinical practice. RMJ, 2004, 14: 876-879.Богова А.В., Ильина Н.И., Лусс Л.В. Тенденции в изучении эпидемиологии аллергических заболеваний в России за последние 10 лет. Рос. аллергол. журн., 2008, 4: 3-15.Bogova AV, Ilyina NI, Luss LV. Trends in the study of the epidemiology of allergic diseases in Russia over the past 10 years. Ross. Allergol Zh, 2008, 4: 3-15.Альбанова В.И., Пампура А.Н. Атопический дерматит: учебное пособие. М., 2014.Albanova VI, Pampura AN. Atopic dermatitis: study guide. M., 2014.Смирнова Г.И. Атопический дерматит у детей: новое в патогенезе, диагностике и лечении. Лечащий врач, 2017, 4.Smirnova GI. Atopic dermatitis in children: new in the pathogenesis, diagnosis and treatment. Lechashchy Vrach, 2017, 4Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am, 2010 Aug, 30(3): 269-280. doi: 10.1016/j.iac.2010.06.003.Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am, 2010 Aug, 30(3): 269-280. doi: 10.1016/j.iac.2010.06.003.Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol, 2012, 30(3): 329–334.Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol, 2012, 30(3): 329–334.Варламов Е.Е., Пампура А.Н. Значение филаггрина в развитии атопического дерматита. Российский аллергологический журнал, 2011, 5: 26-30.Varlamov EE, Pampura AN. The role of filaggrin in the development of atopic dermatitis. Rossiyskiy Allergologicheskiy Zhurnal, 2011, 5: 26-30Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms. Clin Rev Allergy Immunol, 2016, 51(3): 315–328.Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms. Clin Rev Allergy Immunol, 2016, 51(3): 315–328.Van Smeden J, Bouwstra JA. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients. Curr Probl Dermatol, 2016, 49: 8–26. doi: 10.1159/000441540.Van Smeden J, Bouwstra JA. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients. Curr Probl Dermatol, 2016, 49: 8–26. doi: 10.1159/000441540.Di ZH, Ma L, Qi RQ, Sun XD, Huo W, Zhang L et al. T Helper Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human Keratinocytes. Chin Med J (Engl), 2016, 129(3): 295–303.Di ZH, Ma L, Qi RQ, Sun XD, Huo W, Zhang L et al. T Helper Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human Keratinocytes. Chin Med J (Engl), 2016, 129(3): 295–303.Kendall AC, Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity. Prog Lipid Res, 2013, 52(1): 141–164.Kendall AC, Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity. Prog Lipid Res, 2013, 52(1): 141–164.Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest, 2012, 122(2): 440– 447.Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest, 2012, 122(2): 440– 447.Allen H et al. The presence and impact of Biofilm-Producing Staphylococci in Atopic Dermatitis JAMA, 2014, 150(3): 260-265.Allen H et al. The presence and impact of Biofilm-Producing Staphylococci in Atopic Dermatitis JAMA, 2014, 150(3): 260-265.Kuo CL, Chen TL, Liao CC, Yeh CC, Chou CL, Lee WR et al. Birth month and risk of atopic dermatitis: a nationwide population-based study. Allergy, 2016, 71(11): 1626–1631.Kuo CL, Chen TL, Liao CC, Yeh CC, Chou CL, Lee WR et al. Birth month and risk of atopic dermatitis: a nationwide population-based study. Allergy, 2016, 71(11): 1626–1631.Пампура А.Н., Варламов Е.Е., Конюкова Н.Г. Пищевая аллергия у детей раннего возраста. Педиатрия, 2016, 95(3): 152-157.Pampura AN, Varlamov EE, Konyukova NG. Food allergies in young children. Pediatriya, 2016, 95 (3): 152157Lifschitz C, Szaewska H. Cow’smilk allergy: evidencebased diagnosis and management for the practitioner. Eur J Pediatr, 2015, 174(2): 141– 150.Lifschitz C, Szaewska H. Cow’smilk allergy: evidencebased diagnosis and management for the practitioner. Eur J Pediatr, 2015, 174(2): 141– 150.Urisu A, Kondo Y, Tsude I. Hen’s Egg Allergy. Chem Immunol Allergy, 2015, 101: 124–130.Urisu A, Kondo Y, Tsude I. Hen’s Egg Allergy. Chem Immunol Allergy, 2015, 101: 124–130.Тренева М.С., Мунблит Д.Б., Иванников Н.Ю., Лиханова Л.А., Пампура А.Н. Распространенность атопического дерматита и реакций на пищевые продукты у московских детей в возрасте 2 лет. Педиатрия, 2014, 93(3): 11–14.Treneva MS, Munblit, DB, Ivannikov NYu, Likhanova LA, Pampura AN. Prevalence of atopic dermatitis and food reactions in Moscow children aged 2 years. Pediatriya, 2014, 93 (3): 11–14Kattan JD, Cocco RR, Jarvinen KM. Milk and soy allergy. Pediatr Clin North Am, 2011, 58(2): 407– 426.Kattan JD, Cocco RR, Jarvinen KM. Milk and soy allergy. Pediatr Clin North Am, 2011, 58(2): 407– 426.Consortium HMJRS, Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, Rusch DB, Mitreva M, Sodergren E, Chinwalla AT, Feldgarden M, Gevers D, Haas BJ, Madupu R, Ward DV, Birren BW, Gibbs RA, Methe B, Petrosino JF, Strausberg RL, Sutton GG, White OR, Wilson RK, Durkin S, Giglio MG, Gujja S, Howarth C, Kodira CD, Kyrpides N, et al. A catalog of reference genomes from the human microbiome. Science, 2010, 328: 994– 999.Consortium HMJRS, Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, Rusch DB, Mitreva M, Sodergren E, Chinwalla AT, Feldgarden M, Gevers D, Haas BJ, Madupu R, Ward DV, Birren BW, Gibbs RA, Methe B, Petrosino JF, Strausberg RL, Sutton GG, White OR, Wilson RK, Durkin S, Giglio MG, Gujja S, Howarth C, Kodira CD, Kyrpides N, et al. A catalog of reference genomes from the human microbiome. Science, 2010, 328: 994– 999.Bilal JA, Ahmad MI, Robaee AA, Alzolibani AA, Shobaili HA, Al-Khowailed MS. Pattern of bacterial colonization of atopic dermatitis in Saudi children. J Clin Diagn Res, 2013, 7(9): 1968– 1970.Bilal JA, Ahmad MI, Robaee AA, Alzolibani AA, Shobaili HA, Al-Khowailed MS. Pattern of bacterial colonization of atopic dermatitis in Saudi children. J Clin Diagn Res, 2013, 7(9): 1968– 1970.Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol, 2013, 13(5): 514–520.Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol, 2013, 13(5): 514–520.Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res., 2012, 22: 850–9.Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res., 2012, 22: 850–9.Gioti A, Nystedt B, Li W et al. Genomic insights into the atopic eczema-associated skin commensal yeast Malassezia sympodialis. mBio, 2013, 4: e00572–00512.Gioti A, Nystedt B, Li W et al. Genomic insights into the atopic eczema-associated skin commensal yeast Malassezia sympodialis. mBio, 2013, 4: e00572–00512.Patrick L, Zeeuwen M, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, van Swam II, van Hijum SA, Kleerebezem M, Schalkwijk J, Timmerman HM. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol, 2012, 13: 101.Patrick L, Zeeuwen M, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, van Swam II, van Hijum SA, Kleerebezem M, Schalkwijk J, Timmerman HM. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol, 2012, 13: 101.Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol, 2008, 158: 442–455.Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol, 2008, 158: 442–455.Silva SH, Guedes AC, Gontijo B, Ramos AM, Carmo LS, Farias LM, Nicoli JR. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol, 2006, 20(9): 1114– 1120.Silva SH, Guedes AC, Gontijo B, Ramos AM, Carmo LS, Farias LM, Nicoli JR. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol, 2006, 20(9): 1114– 1120.Dotterud LK, Wilsgaard T, Vorland LH, Falk ES. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int J Circumpolar Health, 2008, 67(2–3): 254–260.Dotterud LK, Wilsgaard T, Vorland LH, Falk ES. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int J Circumpolar Health, 2008, 67(2–3): 254–260.Marrs T, Flohr C. The Role of Skin and Gut Microbiota in the Development of Atopic Eczema. British Journal of Dermatology, 2016, 2: 13-18. https: //doi.org/10.1111/bjd.14907.Marrs T, Flohr C. The Role of Skin and Gut Microbiota in the Development of Atopic Eczema. British Journal of Dermatology, 2016, 2: 13-18. https: //doi.org/10.1111/bjd.14907.Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L and Jenmalm MC. Low Gut Microbiota Diversity in Early Infancy Precedes Asthma at School Age. Clinical & Experimental Allergy, 2014, 44: 842-850. https: //doi.org/10.1111/cea.12253.Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L and Jenmalm MC. Low Gut Microbiota Diversity in Early Infancy Precedes Asthma at School Age. Clinical & Experimental Allergy, 2014, 44: 842-850. https: //doi.org/10.1111/cea.12253.Bantz SK, Zhu Z and Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. Journal of Clinical and Cellular Immunology, 2014, 5: 202.Bantz SK, Zhu Z and Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. Journal of Clinical and Cellular Immunology, 2014, 5: 202.Marrs T, Flohr C. The role of skin and gut microbiota in the development of atopic eczema. Br J Dermatol, 2016, 175(2): 13–18.Marrs T, Flohr C. The role of skin and gut microbiota in the development of atopic eczema. Br J Dermatol, 2016, 175(2): 13–18.Brown EM, Arrieta MC, Finlay BB. A fresh look at the hygiene hypothesis: how intestinal microbial exposure drives immune effector responses in atopic disease. Semin Immunol, 2013, 25(5): 378–387.Brown EM, Arrieta MC, Finlay BB. A fresh look at the hygiene hypothesis: how intestinal microbial exposure drives immune effector responses in atopic disease. Semin Immunol, 2013, 25(5): 378–387.Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol, 2001, 108: 516-520.Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol, 2001, 108: 516-520.Renz-Polster H, David MR, Buist AS, Vollmer WM, O’Connor EA, Frazier EA, Wall MA. Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy, 2005, 35: 1466-1472.Renz-Polster H, David MR, Buist AS, Vollmer WM, O’Connor EA, Frazier EA, Wall MA. Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy, 2005, 35: 1466-1472.Захарова И.Н., Бережная И.В., Мачнева Е.Б., Кучина А.Е., Облогина И.С. Грудное молоко – первый шаг к программированию здоровья в течение последующей жизни. Вестник Росздравнадзора, 2018, 1: 28-34.Zakharova, IN, Berezhnaya IV, Machneva EB, Kuchina AE, Oblogina IS. Breast milk: the first step to health programming during later life. Vestnik Roszdravnadzora, 2018, 1: 28-34.Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr, 2000, 30(2): 8-17.Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr, 2000, 30(2): 8-17.Cabana MD, McKean M, Wong AR, Chao C, Caughey AB. Examining the hygiene hypothesis: the Trial of infant probiotic supplementation. Paediatr Perinat Epidemiol, 2007, 21(3): 23-28.Cabana MD, McKean M, Wong AR, Chao C, Caughey AB. Examining the hygiene hypothesis: the Trial of infant probiotic supplementation. Paediatr Perinat Epidemiol, 2007, 21(3): 23-28.Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J Allergy Clin Immunol, 2007, 119(4): 1019-1021.Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J Allergy Clin Immunol, 2007, 119(4): 1019-1021.Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol, 2010, 7(9): 503-514.Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol, 2010, 7(9): 503-514.FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 2006, 88: 1–36.FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 2006, 88: 1–36.Лахтин В.М., Афанасьев С.С., Алешкин В.А., Несвижский Ю.В., Поспелова В.В., Лахтин М.В. и соавт. Стратегические аспекты конструирования пробиотиков будущего. Вестник РАМН, 2008, 2: 33–44.Lakhtin VM, Afanasyev SS, Aleshkin VA, Nesvizhsky YuV, Pospelova VV, Lakhtin MV, et al. Strategic aspects of the development of probiotics of the future. Vestnik RAMN, 2008, 2: 33–44.Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr, 2010, 140(3): 713–721.Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr, 2010, 140(3): 713–721.Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy, 2013, 43(9): 1048–1157.Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy, 2013, 43(9): 1048–1157.Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics, 2013, 132(3): 666– 676.Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics, 2013, 132(3): 666– 676.Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol, 2008, 122(4): 788-794.Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol, 2008, 122(4): 788-794.Ouwehand AC. Antiallergic Effects of Probiotics. J Nutr, 2007, 137: 794–797.Ouwehand AC. Antiallergic Effects of Probiotics. J Nutr, 2007, 137: 794–797.Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol, 2012, 130(6): 1355–1360.Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol, 2012, 130(6): 1355–1360.Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, Double-Blind, PlaceboControlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation. Pediatrics, 2008, 121(4): 850–856.Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, Double-Blind, PlaceboControlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation. Pediatrics, 2008, 121(4): 850–856.Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah LJ, Axelrad C, Moore S, Donath S, Carlin JB, Lahtinen SJ, Tang ML. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy, 2011, 66: 509–516.Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah LJ, Axelrad C, Moore S, Donath S, Carlin JB, Lahtinen SJ, Tang ML. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy, 2011, 66: 509–516.The Royal Australian College of General Practitioners (RACGP) General Practice: Health of the Nation 2017 https: //www.racgp.org.au/your-practice/guidelines/handi/interventions/children/probiotics-in-pregnancy-for-infantatopiceczema/The Royal Australian College of General Practitioners (RACGP) General Practice: Health of the Nation 2017 https: //www.racgp.org.au/your-practice/guidelines/handi/interventions/children/probiotics-in-pregnancy-for-infantatopiceczema/

The authors declare that there are no conflicts of interest present.